University of Tartu

• Reedik Mägi

  Lead investigator

• Elin Org

  Lead investigator

• Andres Metspalu

  Lead investigator

Sources: openalex.org

• NCT05804513

  Phase 4, Status unknown, 10 people, 7 Apr 2023

• NCT04865744

  Phase 4, Completed, 10 people, 29 Apr 2021

• NCT03927950

  Phase 4, Completed, 135 people, 25 Apr 2019

• NCT03160261

  Phase 4, Completed, 10 people, 19 May 2017

• NCT02089256

  Phase 4, Completed, 10 people, 17 Mar 2014

• Haridus- ja Teadusministeerium

  Center of Excellence (TK), Centre of Excellence for Personalised Medicine, TK214, €7m, 2024–2030, 1 Jan 2024

• Eesti Teadusagentuur

  Personal research funding: Team grant (PRG), Improving colorectal cancer screening and prediction using microbiome-based biomarkers, PRG1414, €952.9k, 2022–2026, 1 Jan 2022

• Eesti Teadusagentuur

  Mobilitas Pluss ERA-NET support, Utilising myocardial infarction genes for better treatment (druggable-MI-genes), MOBERA15, €145.4k, 2018–2022, 1 Sept 2018

• Eesti Teadusagentuur

  Personal Research Funding (PUT), The interplay between gut microbiota and metformin treatment in type 2 diabetes through bile acid metabolism, PUT1371, €222.2k, 2017–2021, 1 Jan 2017

• European Molecular Biology Organization

  EMBO Installation Grantee, The interplay between gut microbiota and metformin treatment in type 2 diabetes through bile acid metabolism, 2749, 2017–2023, 1 Jan 2017

Sources: openalex.org